InflaRx (IFRX) Interest Coverage Ratio Growth (3y) (2019 - 2026)
InflaRx (IFRX) Interest Coverage Ratio Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
-16.86% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
InflaRx |
764.68 Mn |
764.68 Mn |
10,877.40 |
633,172.44% |
| Date | Value |
|---|
| Mar 31, 2026 |
633,172.44% |
| Dec 31, 2025 |
-23.80% |
| Sep 30, 2025 |
806,957.45% |
| Jun 30, 2025 |
204.21% |
| Mar 31, 2025 |
73.98% |
| Dec 31, 2024 |
13,015.81% |
| Sep 30, 2024 |
31.69% |
| Jun 30, 2024 |
-27.28% |
| Mar 31, 2024 |
7.82% |
| Dec 31, 2023 |
35.95% |
| Sep 30, 2023 |
52.56% |
| Jun 30, 2023 |
-14.13% |
| Mar 31, 2023 |
-99.99% |
| Dec 31, 2022 |
8,692.61% |
| Sep 30, 2022 |
-25.99% |
| Jun 30, 2022 |
48.46% |
| Mar 31, 2022 |
50.52% |
| Dec 31, 2021 |
-96.17% |
| Sep 30, 2021 |
311.76% |
| Jun 30, 2021 |
175.09% |
